González-Medina, A., Vila-Casadesús, M., Gomez-Rey, M., Fabregat-Franco, C., Sierra, A., Tian, T. V., . . . Vivancos, A. (2024). Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted Therapy. Clinical cancer research, 30(19), 4491. https://doi.org/10.1158/1078-0432.CCR-23-3780
Citácia podle Chicago (17th ed.)González-Medina, Alberto, et al. "Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted Therapy." Clinical Cancer Research 30, no. 19 (2024): 4491. https://doi.org/10.1158/1078-0432.CCR-23-3780.
Citácia podľa MLA (8th ed.)González-Medina, Alberto, et al. "Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted Therapy." Clinical Cancer Research, vol. 30, no. 19, 2024, p. 4491, https://doi.org/10.1158/1078-0432.CCR-23-3780.